Acuta Capital Partners’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Acuta Capital Partners’s Portfolio DRNA Stock Details DRNA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell
2020 Q2	$4.32M	Sell
2020 Q1	$4.71M	Sell
2019 Q4	$8.54M	Buy
2019 Q3	–	Sell
2019 Q2	$6.06M	Buy
2019 Q1	$4.82M	Buy